Stay updated with breaking news from Jonathan Bornstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jonathan Bornstein, President of Amprius Lab, a subsidiary of Amprius Technologies Inc (NYSE:AMPX), has sold 125,983 shares of the company on April 2, 2024, according to a recent SEC filing.
Shares of Amprius Technologies, Inc. (NYSE:AMPX – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight analysts that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average […]
Oppenheimer restated their outperform rating on shares of Amprius Technologies (NYSE:AMPX – Free Report) in a report released on Friday, Benzinga reports. They currently have a $15.00 price objective on the stock. Several other analysts have also issued reports on AMPX. Roth Mkm initiated coverage on Amprius Technologies in a report on Thursday, January 11th. […]
FNY Investment Advisers LLC purchased a new stake in shares of Amprius Technologies, Inc. (NYSE:AMPX – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 16,000 shares of the company’s stock, valued at approximately $84,000. A number of other hedge funds […]
FNY Investment Advisers LLC purchased a new position in Amprius Technologies, Inc. (NYSE:AMPX – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm purchased 16,000 shares of the company’s stock, valued at approximately $84,000. Other hedge funds and other institutional investors also recently bought and sold […]